Background illustration for clinical trials search

Paid Clinical Trials Bronx

Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 4,047

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for

Recurrent Non-Muscle Invasive Bladder Carcinoma,

Location: New York NY, Hackensack NJ, Harrison NY, Uniondale NY,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase 3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for

Somatostatin Receptor Positive (SSTR+),

Location: New York NY, New Haven CT, Hartford CT, Fairfax VA,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase 3, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for

Systemic Lupus Erythematosus (With and Without Nephritis),

Location: New York NY, East Brunswick NJ, Baltimore MD, Montreal,

Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase 1, Recruiting

A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

for

Breast Cancer Survivors

Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 60 - 70+

Code: NCT06334354

Recruiting

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for

Lymphoma, Lymphoma, Non Hodgkin

Location: New York NY, Philadelphia PA, Grand Rapids MI,

Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07082803

Phase 1, Recruiting

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

for

Anaplastic Lymphoma Kinase, Anaplastic Large Cell Lymphoma

Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07001384

Phase 1, Recruiting

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

for

Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis,

Location: Ridgewood NY, Orange CT, Cheektowaga NY, Toledo OH,

Sponsor: Alebund Pharmaceuticals

Sex: All

Age: 12+

Code: NCT06933472

Phase 3, Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for

Triple Negative Breast Cancer

Location: New York NY, Boston MA, Chicago IL, Aurora CO,

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06908928

Phase 1, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for

Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,

Location: New York NY, Providence RI, Boston MA, Glen Burnie MD,

Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase 2, Recruiting

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

for

Excessive Daytime Sleepiness

Location: New York NY, Eatontown NJ, Lincoln NE

Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70+

Code: NCT07082829

Phase 1, Recruiting

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for

Malignant Neoplasm

Location: New York NY, Valhalla NY, New Brunswick NJ,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase 1, Phase 2, Recruiting

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

for

Neuroblastoma

Location: New York NY

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0+

Code: NCT04936529

Phase 2, Recruiting

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

for

Open Angle Glaucoma (OAG),

Location: New York NY, Boston MA, Charleston SC, Glendale CA

Sponsor: Life Biosciences Inc.

Sex: All

Age: 40 - 70+

Code: NCT07290244

Phase 1, Recruiting

The Prevalence of Directional Preference in the Lumbar Stenosis Population

for

Lumbar Stenosis

Location: Lake Success NY

Sponsor: NYU Langone Health

Sex: All

Age: 48+

Code: NCT07007663

Recruiting

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

for

Heart Transplant, Heart Failure, Transplant; Failure, Heart

Location: New York NY, Durham NC, Chicago IL, Atlanta GA,

Sponsor: XVIVO Perfusion

Sex: All

Age: 18+

Code: NCT06895070

Recruiting

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for

Major Depressive Disorder

Location: New York NY, Cedarhurst NY, Verdun, Charlotte NC,

Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT06963021

Phase 3, Recruiting

Featured

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

for

Multiple Myeloma

Location: New York NY, New Brunswick NJ, Montreal, Toronto,

Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06896916

Phase 1, Recruiting

TAP Block Timing Study

for

Bariatric or General Abdominal Surgeries,

Location: New York NY

Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 65

Code: NCT07064200

Recruiting

A Study of Emapalumab for Pediatric Aplastic Anemia

for

Aplastic Anemia, Cytopenia, Hypocellular Marrow

Location: New York NY, Philadelphia PA, Richmond VA,

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0 - 25

Code: NCT06430788

Phase 2, Recruiting

A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)

for

Non Small Cell Lung Cancer

Location: New York NY

Sponsor: Dizal Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06905197

Phase 1, Recruiting

Paid Clinical Trials Bronx

Filter results

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Interested in new trials?

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

The Prevalence of Directional Preference in the Lumbar Stenosis Population

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

TAP Block Timing Study

A Study of Emapalumab for Pediatric Aplastic Anemia

A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)